Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Tempest Therapeutics, Inc. (OVAS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2022 |
3
| Trojanowski Justin (Corporate Controller) has filed a Form 3 on Tempest Therapeutics, Inc. |
05/03/2022 |
3
| Versant Vantage II, L.P. (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc. |
01/10/2022 |
3
| Rock Springs Capital Management LP (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc. |
08/10/2021 |
3
| Simantov Ronit (Director) has filed a Form 3 on Tempest Therapeutics, Inc. |
07/14/2021 |
3
| Maestas Nicholas (VP of Strategy and Finance) has filed a Form 3 on Tempest Therapeutics, Inc. |
07/06/2021 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc. |
07/06/2021 |
3
| Pellizzari Christine A (Director) has filed a Form 3 on Tempest Therapeutics, Inc. |
06/29/2021 |
3
| Xu Stella (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
06/29/2021 |
3
| Brady Stephen R (CEO) has filed a Form 3 on Millendo Therapeutics, Inc. |
06/29/2021 |
3
| RAAB MICHAEL (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
06/29/2021 |
3
| Woiwode Thomas (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
06/29/2021 |
3
| Lorenzo Pierre (Corporate Controller) has filed a Form 3 on Millendo Therapeutics, Inc. |
06/29/2021 |
3
| Dubensky Thomas W. (President) has filed a Form 3 on Millendo Therapeutics, Inc. |
02/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/19/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/20/2019 |
3
| JOSEPH TAMARA L (General Counsel and Secretary) has filed a Form 3 on Millendo Therapeutics, Inc. |
08/20/2019 |
3
| Zeidan Ryan (Chief Development Officer) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| WHITCOMB RANDALL W (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Owens Julia C. (President and CEO) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Sonsini Peter W. (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| SANDELL SCOTT D (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| MOTT DAVID M (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| MAKOWER JOSHUA (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Makhzoumi Mohamad (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Florence Anthony A. Jr. (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| BASKETT FOREST (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Mohideen Pharis (Chief Medical Officer) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| BARRIS PETER J (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Hindman James M. (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| New Enterprise Associates 15, L.P. (10% Owner) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Hedley Mary Lynne (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
12/11/2018 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
|
|
|